Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KMC Speciality Hospitals (India)NSE:KMCSHIL -1.69%73 Return-on-Tangible-Asset is 19.96% as of Jun. 2026, which is 34% above its 10-year median of 14.93. GuruFocus rates NSE:KMCSHIL with a GF Score™ of 73/100 and a GF Value™ of ₹130.07 (Fairly Valued). The stock has 4 warning signs investors should review. Among 683 Healthcare Providers & Services companies, KMC Speciality Hospitals (India) ranks better than 93.41% on this metric.
The historical rank and industry rank for KMC Speciality Hospitals (India)'s Return-on-Tangible-Asset or its related term are showing as below:
NSE:KMCSHIL'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 7.8 Med: 14.93 Max: 20.41
Current: 18.23
During the past 13 years, KMC Speciality Hospitals (India)'s highest Return-on-Tangible-Asset was 20.41%. The lowest was 7.80%. And the median was 14.93%.
NSE:KMCSHIL's Return-on-Tangible-Asset is ranked better than 93.41% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 2.43
vs NSE:KMCSHIL: 18.23
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
KMC Speciality Hospitals (India) Return-on-Tangible-Asset Related Terms
KMC Speciality Hospitals (India) Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:KMCSHIL vs : Return-on-Tangible-Asset Comparison
For the Medical Care Facilities subindustry, KMC Speciality Hospitals (India)'s Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KMC Speciality Hospitals (India) Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, KMC Speciality Hospitals (India)'s Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where KMC Speciality Hospitals (India)'s Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2026) net income data.
What does a Return-on-Tangible-Asset of 19.96% mean?
KMC Speciality Hospitals (India) (NSE:KMCSHIL) has a Return-on-Tangible-Asset of 19.96% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on KMC Speciality Hospitals (India) and its competitors. This is 34% above median its historical median of 14.93. Over the past decade, KMC Speciality Hospitals (India)'s Return-on-Tangible-Asset has ranged from 7.80 to 20.41. According to the industry distribution chart, KMC Speciality Hospitals (India) ranks #45 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 6.6%.
Is KMC Speciality Hospitals (India)'s Return-on-Tangible-Asset too high?
KMC Speciality Hospitals (India)'s current Return-on-Tangible-Asset of 19.96% is 34% above median its 10-year median of 14.93. Over the past 10 years, this metric has ranged from a low of 7.80 to a high of 20.41. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.43. KMC Speciality Hospitals (India)'s value of 19.96% is 721.4% above this industry median. Based on the distribution chart, KMC Speciality Hospitals (India) ranks #45 out of 683 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, KMC Speciality Hospitals (India) has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does KMC Speciality Hospitals (India)'s Return-on-Tangible-Asset compare to ?
According to the Healthcare Providers & Services industry distribution chart, KMC Speciality Hospitals (India) ranks #45 out of 683 companies for Return-on-Tangible-Asset. This places KMC Speciality Hospitals (India) in the top 7% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 2.43. KMC Speciality Hospitals (India)'s value of 19.96% is 721.4% above this benchmark. Historically, KMC Speciality Hospitals (India)'s own Return-on-Tangible-Asset has ranged from 7.80 to 20.41 over the past decade. While the company's 10-year median is 14.93 vs. the industry median of 2.43, KMC Speciality Hospitals (India) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.43, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KMC Speciality Hospitals (India)'s current Return-on-Tangible-Asset of 19.96% is 721.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on KMC Speciality Hospitals (India) and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KMC Speciality Hospitals (India)'s current Return-on-Tangible-Asset is 19.96%, which is 34% above median its own 10-year median of 14.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KMC Speciality Hospitals (India) stock overvalued right now?
Based on GuruFocus' analysis, KMC Speciality Hospitals (India) (NSE:KMCSHIL) is currently considered Fairly Valued. The stock's GF Value™ is ₹130.07, compared to a current price of ₹139.25 — trading 7.1% above its estimated fair value. The current Return-on-Tangible-Asset is 19.96%, which is 34% above median its 10-year median of 14.93 and 721.4% above the Healthcare Providers & Services industry median of 2.43. KMC Speciality Hospitals (India)'s overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For KMC Speciality Hospitals (India) (NSE:KMCSHIL), the current Return-on-Tangible-Asset is 19.96% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KMC Speciality Hospitals (India) (NSE:KMCSHIL) Overvalued in 2026?
Based on GuruFocus' analysis, KMC Speciality Hospitals (India) stock appears to be overvalued.
The current stock price of ₹139.25 is trading 7.1% above its estimated GF Value™ of ₹130.07.
GuruFocus considers KMC Speciality Hospitals (India) to be Fairly Valued.
Key valuation signals for NSE:KMCSHIL:
Return-on-Tangible-Asset: 19.96% (34% above median its 10-year median of 14.93)
GF Value™: ₹130.07 vs. price of ₹139.25 (7.1% above fair value)
Industry Position: 721.4% above the Healthcare Providers & Services median (#45 of 683)
No single metric tells the full story. See the NSE:KMCSHIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KMC Speciality Hospitals (India) Ltd is a healthcare services and pharmacy company. It is engaged in the business of rendering medical and healthcare services. The company offers varieties of departments and care centers such as cardiac science, neurology and neuroscience, orthopedics, spine surgery, gastroenterology, liver diseases, and transplantation and vascular surgery. The company's sole operating segment is Medical and Healthcare Services. The company operates solely in India.
73GF Score
Get the complete analysis for NSE:KMCSHIL
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:KMCSHIL has been successfully added to your 
